Hsbc Holdings PLC Has $85.11 Million Stock Position in Humana Inc. $HUM

Hsbc Holdings PLC raised its holdings in shares of Humana Inc. (NYSE:HUM) by 9.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 330,794 shares of the insurance provider’s stock after acquiring an additional 27,530 shares during the quarter. Hsbc Holdings PLC owned approximately 0.27% of Humana worth $85,107,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Long Focus Capital Management LLC bought a new stake in Humana during the 3rd quarter worth about $34,212,000. Aberdeen Group plc grew its holdings in shares of Humana by 18.1% in the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after acquiring an additional 43,442 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after acquiring an additional 9,960 shares during the last quarter. Ninety One UK Ltd raised its holdings in Humana by 57.2% during the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after acquiring an additional 40,958 shares in the last quarter. Finally, Sustainable Insight Capital Management LLC raised its holdings in Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after acquiring an additional 4,740 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE HUM opened at $360.78 on Tuesday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average price is $289.14 and its two-hundred day moving average price is $242.42. The company has a market cap of $43.32 billion, a PE ratio of 38.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $380.86.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period last year, the firm posted $11.58 earnings per share. The business’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts predict that Humana Inc. will post 9.04 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.

Analyst Ratings Changes

A number of research firms have weighed in on HUM. Bank of America raised their price target on Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a research note on Thursday, June 4th. The Goldman Sachs Group increased their price objective on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. Robert W. Baird decreased their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $260.00 price target on shares of Humana in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $291.35.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.